Advertisement
Canada markets open in 3 hours 48 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7314
    +0.0016 (+0.22%)
     

  • CRUDE OIL

    82.81
    0.00 (0.00%)
     

  • Bitcoin CAD

    87,416.10
    -3,367.91 (-3.71%)
     

  • CMC Crypto 200

    1,363.72
    -18.85 (-1.36%)
     

  • GOLD FUTURES

    2,337.20
    -1.20 (-0.05%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,505.75
    -158.75 (-0.90%)
     

  • VOLATILITY

    16.20
    +0.23 (+1.44%)
     

  • FTSE

    8,085.22
    +44.84 (+0.56%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6814
    -0.0005 (-0.07%)
     

Chimerix: 4Q Earnings Snapshot

Associated Press
Updated ·1 min read

DURHAM, N.C. (AP) _ Chimerix Inc. (CMRX) on Thursday reported a loss of $11.7 million in its fourth quarter.

On a per-share basis, the Durham, North Carolina-based company said it had a loss of 19 cents.

The biopharmaceutical company posted revenue of $1.1 million in the period.

For the year, the company reported that its loss narrowed to $43.5 million, or 70 cents per share. Revenue was reported as $5.4 million.

Chimerix shares have more than doubled since the beginning of the year. The stock has risen fivefold in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CMRX at https://www.zacks.com/ap/CMRX